Massachusetts General Hospital: Generalized Anxiety Disorder trials

The registry lists 11 Generalized Anxiety Disorder studies with Massachusetts General Hospital as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 4 5No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Improving Attentional and Cognitive Control in the Psychological Treatment of Intrusive ThoughtsCompletedNCT04225624Not applicableResults posted
• A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac PatientsCompletedNCT01201967Phase 4Results posted
• Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine EffectsCompletedNCT01033851Phase 4Results posted
• Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar DisorderTerminatedNCT00374543Phase 4Results posted
• Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety DisorderCompletedNCT00113295Phase 4Results posted
• Transcranial Pulse Near-Infrared Light in Generalized Anxiety Disorder: a Placebo-Controlled StudyTerminatedNCT03420456Not applicable
• The Role of Cognitive Control in the Transdiagnostic Conceptualization of "Intrusive Thoughts"CompletedNCT03414619Not applicable
• Pragmatic Collaborative Care for Cardiac Inpatients With Depression or AnxietyCompletedNCT03118752Not applicable
• Stress Reduction and Anxiety: Effects on the Function and Structure of the BrainCompletedNCT01128309Not applicable
• Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed ProfessionalsActive, not recruitingNCT01075672Not applicable
• Aripiprazole for the Treatment of Refractory AnxietyCompletedNCT00438386Phase 4